|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Immune checkpoint inhibitor-related hepatotoxicity:A review显示文摘The application of immune checkpoint inhibitors(ICI)in advanced cancer has been a major development in the last decade.The indications for ICIs are constantly expanding into new territory across different cancers,disease stages and lines of therapy.With this increased use,adverse events including immune checkpoint inhibitor-related hepatotoxicity(ICH)have emerged as an important clinical problem.This along with the introduction of ICI as first-and second-line treatments for advanced hepatocellular carcinoma makes ICH very relevant to gastroenterologists and hepatologists.The incidence of ICH varies between 1%-20%depending on the number,type and dose of ICI received.Investigation and management generally involve excluding differential diagnoses and following a stepwise escalation of withholding or ceasing ICI,corticosteroid treatment and adding other immunosuppressive agents depending on the severity of toxicity.The majority of patients with ICH recover and some may even safely recommence ICI therapy.Guideline recommendations are largely based on evidence derived from retrospective case series which highlights a priority for future research. | Devika Remash David S Prince Catriona McKenzie Simone I Strasser Steven Kao Ken Liu | 2021 | World Journal of Gastroenterology2021，27，32： | 9 |
| 2 | Modelling the spatial and temporal varia- tions of the water balance for the Water catchment 1965 - 1994显示文摘 | Strasser U I Manser W | 2001 | Journal of Hydrology2001，254，1： | 1 |
| 3 | Hyperoxia changes the balance of the thioredoxin/peroxiredoxin system in the neonatal rat brain 显示文摘 | Bendix I Weichelt U Strasser K | 2012 | Brain Res2012，1484，： | 1 |
| 4 | Role of early minimal-invasive spine fixation in acute thoracic and lumbar spine trauma显示文摘 | Oliver I Schmidt Sergej Strasser Victoria Kaufmann | 2007 | Indian J Orthop2007，41，4： | 1 |
| 5 | Non-covalent presentation of sulfamethoxazole to human CD4+ T cells is independent of distinct human leucocyte antigen-bound peptides显示文摘 | Burkhart C Britschgi M Strasser I | 2002 | Clin Exp Allergy2002，32，11： | 1 |
| 6 | Gender differences in implicit theories of wisdom显示文摘 | Glück J Strasser I Bluck S | | 0，，01： | 1 |
| 7 | A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxis 显示文摘 | Angus P W Patterson S J Strasser S I | 2008 | Hepatology2008，48，5： | 1 |
| 8 | Hepatitis viruses and hematopoetic cell transplantation:a guide to patient and donor management显示文摘 | STRASSER S I MCDONALD G B | 1999 | Blood1999，93，： | 1 |
| 9 | Modelling the spatial and temporal variations of the water balance for the Water catchment 1965-1994显示文摘 | Strasser U I Mauser W | 2001 | Journal of Hydrology2001，254，1： | 1 |
| 10 | Age dependence of signal transduction and cell signting as a major factor of intervention into the aging process显示文摘 | Niedermuller H Basota I Strasser A | 2001 | Arch G erontol Geriat2001，33，： | 1 |
| 11 | Hepatitis C virus infection and bone marrow transplanta tion:a cohort study with 10-year follow-up显示文摘 | STRASSER S I MYERSON D SPURGEON C L | 1999 | Hepatol ogy1999，29，： | 1 |
| 12 | Hyperoxia chan- ges the balance of the thioredoxin/peroxiredoxin system in the neonatal rat brain显示文摘 | I Bendix U Weichelt K Strasser | 2012 | Br Res2012，1484，： | 1 |
| 13 | Prevalence and outcomes of pancreatic cystic neoplasms in liver transplant recipients显示文摘AIM To determine the prevalence,characteristics and clinical course of pancreatic cystic neoplasms(PCNs) in liver transplantation(LT) recipients.METHODS We retrospectively studied consecutive patients who underwent LT between January 1998 to April 2016. Clinical and laboratory data were obtained from patient medical records. Imaging findings on computed tomography and magnetic resonance cholangiopancreatography were reviewed by two radiologists.RESULTS During the study period,872 patients underwent cadaveric LT. Pancreatic cysts were identified in 53/872(6.1%) and 31/53(58.5%) were PCNs [28 intraductal papillary mucinous neoplasm(IPMN),2 mucinous cystic neoplasm(MCN),1 serous cystadenoma]. Patients with PCNs exhibited less male predominance(55% vs 73%,P = 0.03) compared to patients without pancreatic cysts. Thirteen patients(42%) were diagnosed with PCN pre-LT while 18 patients(58%) developed PCN post-LT. The median size of PCNs was 13 mm [interquartile range(IQR) 10-20 mm]. All IPMNs were side-branch type. Most PCNs were found in the head and body of pancreas(37% each),followed by the tail(25%). Five patients underwent further evaluation with endoscopic ultrasound. Progress imaging was performed on 81% of patients. PCNs remained stable in size and number in all but 2 patients. During a median follow up of 39 mo(IQR 26-58 mo),the 2(6%) patients with MCN underwent pancreatectomy. No PCN patient developed pancreatic adenocarcinoma,while 5 died from illnesses unrelated to the PCN. Among patients without PCN,1/841(0.1%) developed pancreatic adenocarcinoma.CONCLUSION The prevalence of PCNs in LT recipients was similar to the general population(3.6%,31/872). Side-branch IPMNs do not appear to have accelerated malignant potential in post-LT patients,indicating the current surveillance guidelines are applicable to this group. | Ken Liu Vikram Joshi Louise van Camp Qi-Wei Yang Judith E Baars Simone I Strasser Geoffrey W McCaughan Avik Majumdar Payal Saxena Arthur J Kaffes | 2017 | World Journal of Gastroenterology2017，23，48： | 0 |
| 14 | Patients with non-viral liver disease have a greater tumor burden and less curative treatment options when diagnosed with hepatocellular carcinoma显示文摘AIM To assess the impact of underlying liver disease etiology on the presenting features and outcomes in a large cohort of patients with hepatocellular carcinoma(HCC). METHODS A prospective database of all patients with HCC was established from 1998 to March 2012. One thousand and seventy-eight patients were categorized into three groups, based on the etiology of their liver disease: hepatitis B virus(HBV), hepatitis C virus(HCV) and non-viral liver disease(NVLD). Overall survival was determined by Kaplan Meier analysis to time of death or last follow-up.RESULTS HCC patients with HCV(85%) were more likely to be diagnosed as part of a surveillance program, compared to HBV or NVLD(both 71%)(P < 0.001). Patients with NVLD were more likely to receive best supportive care(29%) compared to those with HBV(21%) or HCV(20%)(P < 0.02). Twelve percent of NVLD and 13% of HBV patients underwent liver transplantation compared to 21% of HCV patients(P = 0.001). Median survival from presentation was lowest in NVLD(1.7 years) when compared to HBV(2.8 years) and HCV(2.6 years)(P < 0.05). In multivariate analysis, independent predictors of survival included Child Turcotte Pugh score, size of dominant lesion, absence of vascular invasion, and management with surgical resection or liver transplantation. Patient age and the etiology of the underlying liver disease were not independent predictors of survival CONCLUSION Patients with NVLD and HCC were less likely to be enrolled in a HCC surveillance program and are less likely to have curative therapies such as liver resection and transplantation after diagnosis with HCC, when compared to patients with Hepatitis B and Hepatitis C. | Waled Mohsen Marcia Rodov Emilia Prakoso Barbara Charlton David G Bowen David J Koorey Nicholas A Shackel Geoffrey W McCaughan Simone I Strasser | 2017 | World Journal of Gastroenterology2017，23，15： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员